Teva Pharma's Generics Azilsartan Medoxomil Receives Tentative Approval in US
Zydus Lifesciences announced on Thursday that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets, which are used to treat high blood pressure. The USFDA's tentative approval covers Azilsartan Medoxomil tablets in strengths of 40 mg and 80 mg.
Zydus Pharms Usa Inc Generic Azilsartan Medoxomil;Chlorthalidone Receives Tentative Approval in US
Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.
Lupin receives approval from USFDA for hypertension tablets
Lupin Ltd Generic Azilsartan Kamedoxomil Receives Approval in the U.S.
FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.
FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide
Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) azilsartan medoxomil tablets, 40 mg, and 80 mg to market a generic equivalent of Edarbi tablets, 40 mg, and 80 mg, of Arbor Pharmaceuticals, LLC.
Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) azilsartan medoxomil tablets, 40 mg, and 80 mg to market a generic equivalent of Edarbi tablets, 40 mg, and 80 mg, of Arbor Pharmaceuticals, LLC.